FocusChem

FocusChem, officially known as Shandong Focus Biotechnology, is a leading global manufacturer of sodium hyaluronate (hyaluronic acid) produced via microbial fermentation. The company operates state-of-the-art GMP facilities and supplies various grades of hyaluronic acid to the pharmaceutical, cosmetic, and food industries worldwide. Its product portfolio includes specialized grades for intra-articular injections, ophthalmic solutions, and topical skincare formulations. In 2019, the company was acquired by Lushang Freda Pharmaceutical, a major Chinese healthcare conglomerate, enhancing its research and production capabilities. FocusChem is recognized for its high-purity standards and extensive international certifications, including CEP and US FDA filings.